Capturing Fluid Spills in Hospital Operating Theatres

/in , , , /by

Fluid spills in hospital operating theatres—such as blood, saline, irrigation fluids, and other bodily fluids—are both common and potentially hazardous. Effective capture and management of these fluids are essential for patient safety, staff protection, infection control, and operational efficiency.

Sources and Risks of Fluid Spills

Fluid spills in operating theatres arise from multiple sources, including bodily fluids, surgical irrigation, suction overflow, accidental dislodgement of tubing, and leakage from equipment or containers. While these fluids are often an unavoidable part of surgery, unmanaged spills can create serious risks. These include:

  • Slip and fall hazards for surgical teams
  • Increased risk of infection due to contamination
  • Electrical hazards when fluids reach powered equipment
  • Workflow disruptions and prolonged procedure times
  • Reduced theatre turnaround time due to the need to clean spills
  • Damage to flooring and infrastructure over time

Because operating theatres must maintain strict aseptic conditions, even minor spills require prompt and appropriate management.

Common Fluid Capture Solutions

Several solutions are used in operating theatres to manage and capture fluid spills effectively:

  1. Absorbent Floor Mats and Pads
    Specialized absorbent mats are placed in high-risk areas around the operating table. These mats are designed to rapidly absorb fluids. They include:

    1. Superabsorbent mats that absorb large amounts of fluid and turn it to gel for quick and easy, non-drip disposal in clinical waste.
    2. Absorbent anti-skid mats that can be walked on whilst still absorbing fluids.
    3. Hybrid walkable/superabsorbent mats that combine high levels of absorbency with a section that can be stood on or have a chair placed on it.
  2. Surgical Drape Systems with Fluid Collection
    Advanced surgical drapes incorporate integrated channels and pouches that direct fluids away from the operative field into collection reservoirs.
  3. Suction-Based Fluid Management Systems
    Dedicated suction devices collect irrigation fluids continuously during procedures, minimizing pooling on surfaces.

Benefits of Proactive Fluid Capture

Implementing effective fluid capture strategies delivers measurable benefits:

  • Enhanced staff safety through reduced slip hazards
  • Improved infection control by limiting environmental contamination
  • Shorter turnaround times between procedures due to faster clean-up
  • Lower long-term maintenance costs by protecting floors and equipment
  • Greater compliance with health and safety regulations

In high-volume operating suites, these benefits can translate into significant operational and financial gains.

Training and Protocols

Even the best equipment is only effective when used correctly. Staff training is essential to ensure fluid capture measures are deployed consistently and appropriately. Clear protocols should define when and how absorbent mats or other fluid capture tools are used, how waste fluids are disposed of, and how contaminated materials are handled post-procedure.

Looking Ahead for Fluid Spills in Hospital Operating Theatres

As surgical techniques evolve and procedure volumes increase, the demand for smarter, more efficient fluid management solutions will continue to grow. Innovations in materials, equipment, and theatre design are helping hospitals move toward cleaner, safer operating environments where fluid spills are managed proactively rather than reactively.

Effective fluid capture in operating theatres is not just a housekeeping concern—it is a fundamental component of patient safety, staff wellbeing, and high-quality surgical care.

For more information on managing fluid spills in hospital operating theatres with superabsorbent, anti-skid mats and hybrid mats click here.

 

Decontamination in Hospitals: Upcoming Events in 2026

/in , , /by

If you are involved in decontamination in hospitals, there are a raft of insightful events over the coming months. Read on to find out more.

The Central Sterilisation Club Annual Scientific Meeting 2026
20th to 21st April, Nottingham.

This event will cover a number of important topics including:

  • How to balance the risk of reprocessing orthopaedic implants compared to using single-use implants, and how to address the challenges that come with cleaning complex reusable tools.
  • The risks of misguided sustainability decisions; equipping decontamination leads with evidence to counter ill-informed demands.
  • How to ensure effective cleaning and standard compliance in endoscope decontamination in hospitals
  • A debate on whether the UK should abandon HTM’s in favour of international standards.

For more information on this event click here.

 

DECON UK 2026
24th April, Molineux Stadium, Wolverhampton

The Royal Wolverhampton NHS Trust, University Hospitals Birmingham NHS Foundation Trust and Walsall Healthcare NHS Trust jointly bring you this free event, which covers a range of topics including:

  • Decontamination within Pharmacy Aseptic Services – is it possible to be compliant and sustainable at the same time?
  • The future of Decontamination and Sustainability.
  • Can you be clean, green and lean? An environmentally sustainable approach to choosing decontamination methods.
  • Ultraviolet water trap technology, peracetic acid and air sampling.

For more information on this event click here.

 

Decontamination and Sterilisation 2026
29th April, National Conference Centre, Birmingham

Bringing together frontline experts, NHS leaders and innovators shaping the future of sterile services, this event focuses on real-world practice, regulatory insight, and emerging technology.

The event programme offers practical advice for teams working across decontamination, infection control, and clinical science.

Presentation topics include:

  • The impact of accelerated digital transformation on the sector and workforce skills and capability requirements.
  • Discussing the role of JAG in the assessment of decontamination services, critical to the quality and safety of endoscopy services.

For more information on this event on decontamination in hospitals click here.

 

Theatres and Decontamination Conference
19th May, Radisson Blu, Stanstead

This event brings together industry experts, healthcare professionals, and innovators to explore the latest advancements, challenges, and best practices in operating theatre management, decontamination, and infection prevention.

This year’s programme includes a wide range of presentations and debates on topics such as:

  • Collaborative working across healthcare teams
  • Robotics and medical device innovation, including AI
  • The circular economy and sustainability in healthcare
  • How to align with the latest best practice and standards

Click here to find more information on this event.

 

Decontamination in Hospitals

Interested in more event updates and article about sterilisation and decontamination in hospitals?

Just click here and bookmark our blog.

Or if you would like to find out about our workplace exposure monitoring services for decontamination, sterile services, and endoscopy departments in hospitals, please click here for more information.

Cairn’s Carbon Reduction Plan 2025 shows reduced carbon emissions

/in , /by

Cairn Technology has published its Carbon Reduction Plan 2025, showing decreases in carbon emissions for both Scope 1 and Scope 2 figures.

Scope 1 emissions – 100% offset

The reduction in Scope 1 emissions is due to changing more of our vehicle fleet to hybrid cars, so that our field-based consultants are travelling in a way that is more environmentally friendly.

Our Scope 1 environmental management objective, which began in 2023, remains to increase the number of lower emitting transport types year on year, whenever possible.

In addition, we have offset all of our Scope 1 emissions for 2025 by continuing to invest in the Carbon Footprint UK Tree Planting Scheme, supporting both carbon capture and environmental biodiversity.

Commitment to Scope 2 emissions reduction

Our Scope 2 carbon emission total also saw a small decrease from 2024, reflecting our effort to be mindful of our consumption, and our drive to be more energy efficient.

Our aim is to further reduce our Scope 2 emissions in 2026 by purchasing our electricity from renewable sources. The end of a fixed supplier contract in 2026 will allow us to implement this important change.

Scope 3 emissions reduced for Category 4

Overall, we have seen a modest increase in our Scope 3 emissions in our 2025 Carbon Reduction Plan.

In particular, our category 9 total has increased by 18%. This is due, in part to an 8% increase in the sales of our absorbent mat products, which are shipped from our EU manufacturing base.

However, we succeeded in reducing our category 4 emissions total compared to our 2024 figures, by consolidating supply shipments wherever possible.

In addition, we have continued to make efforts to reduce other sources of carbon emissions in Scope 3, including:

  • reducing employee commuting with a hybrid working-from-home approach,
  • recycling as much waste generated from our office and warehouse space as possible, such as reusing packaging in our warehouse where appropriate, and
  • encouraging our sales team to conduct business meetings with clients virtually where possible.

Find out more about our Carbon Reduction Plan 2025 Report

Want to know more? Just click here for our full Carbon Reduction Plan Report for 2025

Cytotoxic Drug Spills – the Risks in Hospitals

/in , /by

Cytotoxic drug spills pose significant risks to healthcare workers, patients, and the hospital environment. Understanding these risks—and how to prevent and manage them—is critical to maintaining a safe healthcare setting.

What Are Cytotoxic Drugs?

Cytotoxic drugs, also known as antineoplastic or chemotherapy agents, are essential in the treatment of cancer and other serious conditions. They are designed to kill or inhibit the growth of rapidly dividing cells. While this makes them effective against cancer, it also means they can damage healthy cells. Many cytotoxic agents are classified as hazardous because they are toxic, carcinogenic, mutagenic, teratogenic, or capable of causing organ damage even at low levels of exposure.

How Cytotoxic Drug Spills Occur

Spills can occur at various points in the medication-use process, including:

  • Preparation and compounding in pharmacies
  • Transport within the hospital
  • Administration to patients
  • Disposal of drug waste and contaminated materials

Contributing factors include inadequate training, equipment failure, poor handling techniques, high workloads, and lack of appropriate spill-response resources.

Health Risks to Healthcare Workers

Exposure to cytotoxic drugs can occur through skin contact, inhalation of aerosols, ingestion, or accidental injection. Acute effects may include skin irritation, eye damage, headaches, dizziness, and nausea. Long-term or repeated exposure has been associated with more serious outcomes such as reproductive disorders, infertility, genetic damage, and an increased risk of cancer.

Nurses, pharmacists, cleaning staff, and waste handlers are particularly vulnerable, especially if spills are not promptly identified and properly managed.

Risks to Patients and Visitors

Drug spills in patient care areas can expose non-target individuals, including patients receiving other treatments and hospital visitors. Immunocompromised patients, pregnant individuals, and children are especially at risk. Contaminated surfaces may also contribute to indirect exposure if not adequately cleaned.

Environmental and Operational Impacts

Cytotoxic spills can contaminate hospital surfaces, equipment, and wastewater systems. Improper cleanup may lead to persistent contamination, increasing the likelihood of repeated exposure. In addition, spills can disrupt clinical workflows, require area closures, and lead to costly decontamination efforts and regulatory consequences.

Importance of Spill Management and Prevention

Effective risk reduction relies on a combination of prevention and preparedness, including:

Regular audits, incident reviews, and updates to safety procedures help ensure ongoing compliance and improvement.

Conclusion

Cytotoxic drug spills represent a serious occupational and environmental hazard in hospitals. While these medications are indispensable in modern healthcare, their risks must be carefully managed. Through proper training, robust safety systems, and a strong culture of awareness, hospitals can minimize the likelihood of spills and protect the health of workers, patients, and the broader community.

If you would like help spill training, we can help you and your teams. Just click here for information on our cytotoxic drug spill training.

You can also click here to find out about our Cytotoxic Drug Spill Stations for hospitals and click here for information on our Home Cytotoxic Drug Spill Kits for where the drugs are administered in the patient’s home.

Alternatively, please call our spill management team on 0333 015 4345.

 

Operating Theatre Events in 2026

/in , /by

Looking for some operating theatre events offering useful insights into operating theatre management and efficiency in 2026?

Don’t miss these five events for some great learning and networking experiences.


The Operating Theatres Conference 2026

5th February 2026 | CorpAcq Stadium, Manchester

This 11th Annual Operating Theatres Conference explores the latest innovations, strategies and best practices in operating theatre management. Topics covered include achieving NHS Net Zero, high-intensity theatre (HIT) lists, infection control, and staff wellbeing.

For more information click here.

 

The National Operating Theatres Show 2026

10th March 2026 | The Kia Oval, London

The Institute of Government & Public Policy’s Operating Theatres Show promises a host of learning and networking opportunities for surgeons, senior theatre practitioners and healthcare leaders. Agenda topics include Rebuilding Surgical Capacity; and Transforming Surgical Pathways: Minimally Invasive Approaches and Improving Flow from Community to Theatres.

For more information and the full agenda click here.

 

Theatres and Decontamination Conference 2026

19th May 2026 | Radisson Blu, Stansted

This one-day conference promises presentations from industry experts, healthcare professionals, and innovators to hear about the latest advancements, challenges, and best practices in operating theatre management, decontamination, and infection prevention. In addition, the event includes an exhibition of products and services.

For more information click here.

 

Operating Theatre Conference, EBME Expo 2026

24th to 26th June 2026 | Coventry Building Society Arena

For a range of expert speakers on operating theatre efficiency, safety and developments, plus the opportunity to network with colleagues, sign up to visit this insightful operating theatre conference.

For more information click here.

 

The Annual Operating Theatres Show 2026

10th September | Etihad Stadium, Manchester

This event will bring together clinical leaders, strategic thinkers, operational managers, policymakers, and innovators to tackle issues such as building surgical services fit for the future, driving down waiting times, maximising efficiency, and safeguarding patient care.

For more information click here.

 

Can’t make these operating theatre events?

If you can’t make it to these events, but are looking for a company that can help your operating theatres with workplace exposure monitoring, chemical spill kits and training, or absorbent mats, feel free to call the team at Cairn Technology on 0114 553 6960 or drop us an email at in**@*************gy.com For more information on upcoming operating theatre events, follow our blog now.

Dust risks in hospitals

/in , /by

When it comes to hazardous substances in healthcare environments, it can be easy to overlook the risk that dusts can pose.

Although they can look innocuous, according to NHS Resolution, dust is among the highest occurring hazards in healthcare settings.(1)

In fact, dust and fumes accounted for 37.5% of the settled claims made between 1 April 2013 and 31 March 2023 by healthcare support staff, including plaster technicians and nursing assistants.

Dusts also accounted for 25% of settled claims made during the same period by nurses who are members of the Nursing and Midwifery Council; and for 32% of settled claims overall.

Where do dust risks in hospitals come from?

Dust can come from a variety of sources in hospitals. It can come into hospital buildings from construction, demolition or refurbishment work.

Not only can this lead to respiratory problems due to microscopic particulate, dust can also transport airborne bacteria, leading to lung infections.

Dust is also a natural by-product of prosthetics manufacture, when it is generated during the sanding, grinding, and machining of materials. Likewise, there is a risk from dust when Plaster of Paris or other types of splinting bandages are removed with an oscillating saw.

For this reason, staff working in prosthetic centres, orthotics laboratories and plaster clinics are also at risk of developing respiratory infections from dust.

Monitoring dust exposure in fracture clinic plaster rooms and orthotics laboratories

At Cairn Technology, we have extensive experience in carrying out dust exposure monitoring in fracture clinic plaster rooms and orthotics laboratories.

By measuring your staff’s exposure to total inhalable and respirable dust, we can check levels of these dusts in line with the methods outlined in the HSE Publications MDHS 14/3.

This process simply involves asking delegated members of staff to clip a small filter to clothing which is connected to a sample pump clipped to their waist band. Sampling is carried out during their normal duties.

We then provide you with a report which will show you whether your staff are working within safe exposure limits or if there is any need for improvement.

To ensure continued compliance with Regulation 10 of the Control of Substances Hazardous to Health (COSHH) regulations 2002 (as amended), we recommend that this dust monitoring procedure is carried out once a year.

To discuss our monitoring service for dust risks in hospitals for your hospital or prosthetics centre, or to get a quote, please call us on 0333 015 4345.

 

References:

Handling formalin spills in operating theatres

/in , /by

Formalin spills in operating theatres can pose a significant risk to staff and patients. That said, formalin is not something that can easily be dispensed with.

This is because it plays an important role in the preservation and optimal handling of tissue samples taken from patients in the operating theatre for histological analysis.

This analysis helps medical teams establish clinical diagnoses for patients, allowing them to make informed decisions for further treatment.

As an accurate diagnosis can only be given where the surgical specimen is handled correctly from the point of collection, formalin plays a crucial role in ensuring this.

What is formalin?

Formalin is a formulation of formaldehyde in aqueous solution. It contains around 40% of formaldehyde, which is a gas in normal conditions.

According to the UK Health Security Agency, inhalation of formaldehyde can cause issues such as sore throat and breathlessness and in severe cases issues such as laryngeal and pulmonary oedema. In addition, skin contact may cause irritation and dermatitis, and it is also irritating to the eyes.

As a result, it is perhaps no surprise that formalin is also hazardous and can cause problems with the eyes, skin and respiratory tract. In addition, as of 1st January 2016, the International Agency for Research on Cancer classified formaldehyde as a class 1 carcinogen.

How to handle a formalin spill

The Control of Substances Hazardous to Health Regulations (COSHH) 2002 requires employers to carry out risk assessments on the use of hazardous substances such as formalin, including putting in place the correct equipment and procedures to handle hazardous incidences.

As formalin spillages are a major health hazard, it is important to have the correct chemical spill kits in place to handle the spill quickly and safely.

Not only will this help to minimise the risk to staff and patients, but it will also minimise disruption that could lead to cancelled procedures and delays in histological analysis.

As formalin is used when transporting specimens, the spill might happen in the operating theatre, laboratory, or between those two locations.

As such, it can be a good idea to have a wall-mounted chemical spill station in both the operating theatres and laboratory, which is in a fixed location that staff are all aware of.

If the chemical spill station needs to be available for areas in close proximity to each other, a chemical spill station in a portable case could be a better solution.

These spills must always be handled by two members of staff who are fully trained in using the chemical spill kits and know how to clear up the spill in the correct way.

Looking for a chemical spill station?

Developed in conjunction with NHS staff, our chemical spill stations for formalin spills come in both a wall-mounted version or a fast-response carrying-case version.

For more information on our chemical spill stations for formalin spills click here.

Or if you need staff training to use the spill kits you can click here for details of our chemical spill management training.

Alternatively, call Cairn Technology’s chemical spill consultants on 0333 015 4345.

 

NHS hospitals pay the price for staff exposure to chemicals

/in , /by

Exposure of hospital staff to chemicals is leading to a raft of claims for harm to their health.

According to NHS Resolution(1), they received 371 claims for harm caused by exposure to substances hazardous to health from incidents occurring between 1 April 2013 and 31 March 2023.

Of the 165 claims that were settled during that period, damages totalling £2,471,880 were paid out to claimants, with the NHS also having to pay out for defence costs.

At a time when money is tighter than ever in the NHS, avoiding costly claims is critical. But this is still only a secondary concern to the fact that staff are being wrongfully and dangerously exposed to hazardous substances in the workplace.

What sort of claims are being made?

Whilst the above claims relate to a variety of harmful substances including dust and hand hygiene products, it is interesting to note that a large percentage of claims come from chemicals and fumes.

For nurses (registered with the Nursing and Midwifery Council), 20% of claims arose from exposure to chemicals other than cleaning chemicals, whilst a further 25% came from dust and fumes.

For healthcare support staff the figures are more stark, with 40% of claims arising from exposure to chemicals other than cleaning chemicals, and 37.5% from dust and fumes.

Formalin, Acetic Acid and Peracetic Acid Exposure

Some of the chemicals used in hospitals that can pose a significant risk to healthcare staff are Formalin, Acetic Acid and Peracetic Acid (PAA).

In operating theatres, Formalin is used to preserve surgical tissue specimens for histological and pathological examination.

Formalin (formaldehyde) exposure can lead to eye, skin, nose, and throat irritation, and respiratory issues. A known human carcinogen, if staff are exposed to it over long periods of time in large amounts, they can develop bronchial asthma and possible organ damage.

In endoscopy, PAA is mainly used to sterilize or disinfect endoscopes and other reusable medical instruments after use. If exposed to PAA, staff can experience side effects such as breathing issues, eye or skin irritation, headaches, dizziness, and with higher exposures pulmonary oedema.

What action should hospitals take to protect staff?

The Control of Substances Hazardous to Health Regulations (COSHH) 2002 requires employers to carry out risk assessments on the use of hazardous substances.

This includes putting in place procedures and equipment to handle accidents such as Formalin and PAA spills. Staff must also be given adequate training into how to approach and clear spills safely to minimise the risk to their health.

By using a dedicated chemical spill station for chemicals such Formalin, Acetic Acid and Peracetic Acid, staff can clear spills safely and efficiently, using the correct personal protective equipment.

Some staff may need to use powered air fed respirator hoods where they have not been face-fit tested for the respirators in the chemical spill station or where they have facial hair that can interfere with the effectiveness of the respirator seal.

In addition, all staff should go through chemical spill management training to learn how to use the chemical spill station effectively and safely.

By assessing the risks of spills and providing the correct kit and training, NHS Trusts and private hospitals fulfil the important duty of care that they have for their staff. The result is not only likely to be fewer claims for personal injury, but more importantly far less harm to staff.

Can we help?

With 25 years of experience in handling chemical spills, and a range of spill kits developed in conjunction with healthcare staff, we can provide both the equipment and expertise to help you handle spills safely.

For information on chemical spill stations for Formalin, Acetic Acid and Peracetic Acid click here. Or for air-fed hood information click here.

For information on chemical spill management training click here.

Alternatively, call Cairn Technology’s chemical spill consultants on 0333 015 4345.

 

Absorbent floor mats for veterinary operating theatres

/in , , /by

Are you are looking for an absorbent floor mat for use in your veterinary operating theatres? We offer a range of solutions to help capture fluid and minimise the risk if slips and falls.

T-Mat Superabsorbent Floor Mat

Our superabsorbent T-Mat floor mat is ideal for collecting spills during wet procedures in veterinary surgical theatres.

The mat collects and binds liquids hygienically, turning fluid into a gel within minutes for quick and easy non-drip disposal in clinical waste.

As the most absorbent mat on the UK market, the T-Mat can absorb up to 8.5 litres of water or 3.5 litres of saline. Measuring 75 x 36cm, the T-Mat should be positioned on the floor where you expect fluids to pool.

Its ability to lock in fluids reduces the risk of slips and trips, as well as the time needed to clean up post-procedure.

For more information on this absorbent floor mat for veterinary operating theatres click here.

The DryMax XL Absorbent Anti-Skid Floor Mat

If you are looking for an absorbent mat that you can stand on whilst scrubbing up or performing an operation, then the DryMax XL is the perfect choice.

Designed with an anti-skid barrier layer, the mat stays in place and prevents absorbed fluids from passing through, thereby preventing slips on wet floors.

Measuring 100 x 75cm, the DryMax XL can be conveniently cut to fit an area. Capable of absorbing up to 2 litres of fluid, its non-drip design allows for quick and easy disposal, with minimum risk of cross-infection.

What’s more, it is also available on a 50-meter roll with a dispenser, allowing for neat storage and more economical use of the mat by cutting to the size you require. For information on the DryMax XL mats click here or find out about the DryMax XL Roll by clicking here.

Helping you control spills in your veterinary operating theatres

You can find out how our absorbent mats can help you to collect fluid in veterinary hospitals and operating theatres, by trying some free samples of our mats.

If you would like some free samples, or you are interested in pricing for our mats, please call us on 0333 015 4343 or email in**@*************gy.com. You can also complete our enquiry page here: https://cairntechnology.com/contact/

 

Keeping staff safe from inhalable and respirable dust

/in , /by

Dust monitoring in fracture clinicsIf you manage a fracture clinic plaster room or orthotics laboratory, it is important to ensure that your staff are protected against the risks of inhalable and respirable dust.

This was underlined again only this month in an HSE eBulletin, which revealed that the Health and Safety Executive had recently fined a stone worktop manufacturer £60,000 and a wood supplier £40,000 for failing to protect workers from harmful dust exposure.

Plaster of Paris dust generated in plaster rooms and orthotics laboratories can lead to short-term and long-term respiratory problems.

So, it is vital that employers provide proper ventilation systems, appropriate respiratory protection, and carry out regular health surveillance to protect their workers.

Inhalable and respirable dust monitoring

We carry out workplace exposure monitoring in fracture clinic plaster rooms and orthotics laboratories to measure staff exposure to total inhalable and respirable dust.

Levels of these dusts need to be measured in accordance with the methods outlined in the HSE Publications MDHS 14/3.

Monitoring for workplace exposure to respirable and inhalable dust.To ensure that this is done, we equip each member of staff with personal sampling pumps and monitor their exposure to dust during a normal working period.

We then provide you with a report which details the staff exposure levels and outlines whether there are any causes for concern.

We recommend that this inhalable and respirable dust monitoring procedure should be carried out every 12 months to ensure continued compliance with Regulation 10 of the Control of Substances Hazardous to Health (COSHH) regulations 2002 (as amended).

To discuss our inhalable and respirable dust monitoring service or get a quote, please call us on 0333 015 4345 or email in**@*************gy.com

What about staff exposure to Diisocyanates?

We can also help measure your staff’s exposure for Diisocyanates through our Biological Sampling service.

Diisocyanates are now used more frequently in fracture clinics because of the move away from Plaster of Paris towards synthetic products. They are also being used more widely in prosthetic laboratories where the use of resins is becoming more commonplace.

They are highly reactive substances which are potent respiratory and skin sensitizers and a common cause of asthma and allergic contact dermatitis.

The increase in Diisocyanate usage, along with the British Orthopaedic Association’s adoption of worker training guidance from the EU, has highlighted the importance of monitoring staff exposure.​

We recommend that sampling should be carried out every 12 months to ensure continued compliance with Regulation 10 of the Control of Substances Hazardous to Health (COSHH) regulations 2002 (as amended).

If you are unsure whether or not your department is using products that contain Diisocyanates, our team can establish this on your behalf from the product material data sheets.

To discuss our Diisocyanate biological sampling service or get a quote, please call us on 0333 015 4345 or email us at in**@*************gy.com